Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Glaukos Corporation
< Previous
1
2
3
Next >
Glaukos Announces First Quarter 2024 Financial Results
May 01, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces the Release of its 2023 Sustainability Report
April 16, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
April 10, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
April 03, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
April 01, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results
February 21, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21
January 31, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance
January 09, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
December 20, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)
December 14, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Participation in Stifel Healthcare Conference
November 07, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Third Quarter 2023 Financial Results
November 01, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Academy of Ophthalmology Annual Meeting
October 31, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos to Release Third Quarter 2023 Financial Results after Market Close on November 1, 2023
October 11, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Participation in Wells Fargo Healthcare Conference
August 23, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Second Quarter 2023 Financial Results
August 02, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc.
July 17, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023
July 12, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Achieves Pipeline Milestone with Enrollment Completion in Phase 3 Confirmatory Trial for Epioxa (Epi-on)
June 05, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Participation in the William Blair Growth Stock Conference
May 24, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces FDA Acceptance of NDA Submission for iDose TR
May 05, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces First Quarter 2023 Financial Results
May 03, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting
May 01, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces the Release of its 2022 Sustainability Report
April 19, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos to Release First Quarter 2023 Financial Results after Market Close on May 3
April 12, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Submits New Drug Application to U.S. FDA for iDose TR
February 27, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Fourth Quarter and Full Year 2022 Financial Results
February 22, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Participation in the Citi Healthcare Conference
February 15, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos to Release Fourth Quarter and Full Year 2022 Financial Results after Market Close on February 22
February 01, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Positive Results for iDose TR Exchange Trial, Highlighting Favorable Safety and Tolerability
January 10, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit